Article

Evaluation of the effect of hetastarch and lactated Ringer's solution on plasma colloid osmotic pressure in healthy llamas.

Department of Clinical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331, USA.
Journal of the American Veterinary Medical Association (Impact Factor: 1.67). 03/2011; 238(6):768-72. DOI: 10.2460/javma.238.6.768
Source: PubMed

ABSTRACT To compare the effects of hetastarch and lactated Ringer's solution (LRS) on plasma colloid osmotic pressure (pCOP) and other hematologic variables in healthy llamas.
Prospective crossover study.
6 healthy female llamas. Procedures-Llamas were administered LRS (45 mL/kg [20.5 mL/lb]) and, after a 3-day washout period, hetastarch (15 mL/kg [6.8 mL/lb]) during 60-minute IV infusions. Serum total protein, serum albumin, and hemoglobin concentrations and Hct were measured before each infusion (baseline), immediately after each infusion was completed (0 hours), and at 2, 4, 8, and 12 hours. The pCOP was measured at baseline and at 0, 2, 4, 8, 12, 24, 36, and 48 hours after each infusion was completed; additional measurements of pCOP were obtained 72 and 96 hours after hetastarch infusion.
Hetastarch administration significantly increased mean ± SEM pCOP from 23.5 ± 0.3 mm Hg (baseline) to a peak of 28.4 ± 0.6 mm Hg (12 hours); significant increases in pCOP persisted at 96 hours after hetastarch administration. Administration of LRS significantly decreased albumin and total protein concentrations; in addition, mean ± SEM pCOP decreased from 24.1 ± 0.4 mm Hg (baseline) to 18.0 ± 0.3 mm Hg (0 hours). Hetastarch administration caused more pronounced decreases in Hct (0 hours) and concentrations of hemoglobin (0 hours), albumin (all time points), and total protein (all time points) than did LRS administration.
Hetastarch administration increased pCOP in healthy llamas for 96 hours with no clinically important complications.

0 Bookmarks
 · 
168 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Clinical indications for hydroxyethyl starches (HES) in horses include rapid plasma volume expansion and oncotic support during periods of hypoproteinaemia. Side effects such as coagulopathies associated with HES administration pose limitations to their use in veterinary medicine. In humans, tetrastarch [hydroxyethyl starch (130/0.4)] has demonstrated less profound effects on coagulation compared to 1st and 2nd generation HES. To evaluate the haemostatic and oncotic effects of tetrastarch (130/0.4) administered at 10, 20 and 40 ml/kg bwt in healthy horses. Randomised crossover experiment. Tetrastarch (130/0.4) was administered to 6 healthy pony mares at 10, 20 and 40 ml/kg bwt with a 2-week washout period. Packed cell volume (PCV), total solids (TS), plasma colloid oncotic pressure (pCOP), platelet count and thromboelastography (TEG) was measured at baseline, immediately after infusion (0 h), 1, 6, 12, 24, 48, and 96 h after tetrastarch infusion. All TEG variables remained within normal reference ranges in all 3 treatment groups. Administration of tetrastarch at 40 ml/kg bwt resulted in a prolonged K-time (P = 0.049) at 6 h post-infusion, and decreased maximum amplitude at 0 (P<0.001), 1 (P = 0.022), 6 (P = 0.006), 24 (P<0.001) and 48 h (P = 0.013) post-infusion compared to baseline. Administration of tetrastarch increased mean pCOP values above baseline in all 3 treatment groups, persisting to 24, 6 and 48 h for the 10, 20 and 40 ml/kg bwt dose respectively. Although still within established reference ranges, compared to lower dosages, the administration of 40 ml/kg bwt tetrastarch (130/0.4) is more likely to induce changes in coagulation as measured by TEG. Tetrastarch increased pCOP at all dosages evaluated in healthy horses. Tetrastarch (130/0.4) at 10 and 20 ml/kg bwt has potential as a synthetic colloid for resuscitation and provision of oncotic support in horses.
    Equine Veterinary Journal 12/2013; 46(6). DOI:10.1111/evj.12223 · 2.37 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Body water, electrolytes, and acid-base balance are important considerations in the evaluation and treatment of small ruminants and camelids with any disease process, with restoration of these a priority as adjunctive therapy. The goals of fluid therapy should be to maintain cardiac output and tissue perfusion, and to correct acid-base and electrolyte abnormalities. Hypoglycemia, hyperkalemia, and acidosis are the most life-threatening abnormalities, and require most immediate correction.
    Veterinary Clinics of North America Food Animal Practice 07/2014; 30(2). DOI:10.1016/j.cvfa.2014.04.006 · 1.75 Impact Factor

Full-text

Download
20 Downloads
Available from
May 17, 2014